Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

HIV Infection

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 91 articles: HTML format Text format

Single Articles

March 2010
1. GUPTA S , Fransen S, Paxinos EE, Stawiski E, et al
   Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitor Resistance.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. LI L , He L, Tan S, Guo X, et al
   3-Hydroxyphthalic Anhydride-modified Chicken Ovalbumin Exhibits Potent and Broad Anti-HIV-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. VAN 'T KLOOSTER G , Hoeben E, Borghys H, Looszova A, et al
   Nanosuspension of rilpivirine (TMC278) as a long-acting injectable antiretroviral formulation: pharmacokinetics and disposition.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. PANNECOUQUE C , Szafarowicz B, Volkova N, Bakulev V, et al
   Inhibition of the HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates the zinc ions from the retroviral nucleocapsid zinc fingers.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GRANT PM , Taylor J, Nevins AB, Calvez V, et al
   Antiviral Activity of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase: An International Cohort Analysis.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. GATANAGA H , Ode H, Hachiya A, Hayashida T, et al
   Combination of V106I and V179D Polymorphic Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Efavirenz and Nevirapine but not to Etravirine.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. MORELLO J , Soriano V, Barreiro P, Medrano J, et al
   Plasma ribavirin trough concentrations at week 4 predict HCV relapse in HIV/HCV-coinfected patients treated for chronic hepatitis C.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. WANG G , Watson KM, Peterkofsky A, Buckheit RW Jr, et al
   Identification of Novel Human Immunodeficiency Virus Type 1 Inhibitory Peptides Based on the Antimicrobial Peptide Database.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. PTAK RG , Gentry BG, Hartman TL, Watson KM, et al
   Inhibition of Human Immunodeficiency Virus Type 1 by Triciribine Involves the Accessory Protein Nef.
   Antimicrob Agents Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SHAMIR ER , Warthan M, Brown SP, Nataro JP, et al
    Nitazoxanide Inhibits Biofilm Production and Hemagglutination by Enteroaggregative Escherichia coli Strains by Blocking Assembly of AafA Fimbriae.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BALZARINI J , Francois K, Van Laethem K, Hoorelbeke B, et al
    Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.
    Antimicrob Agents Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. DONAHUE DA , Sloan RD, Kuhl BD, Bar-Magen T, et al
    Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. HURWITZ SJ , Asif G, Fromentin E, Tharnish PM, et al
    Lack of Pharmacokinetic Interaction Between Amdoxovir and Reduced and Standard Dose Zidovudine in HIV-1 Infected Individuals.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. PEATEY CL , Andrews KT, Eickel N, Macdonald T, et al
    Antimalarial asexual stage-specific and gametocytocidal activity of HIV protease inhibitors.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. MAIGA AI , Descamps D, Morand-Joubert L, Malet I, et al
    Resistance Associated Mutations to Etravirine (TMC-125) in Antiretroviral Naive Patients infected with non-B HIV-1 subtypes.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. BARRAIL-TRAN A , Mentre F, Cosson C, Piketty C, et al
    Influence of alpha 1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in ANRS107 trial.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. BARAU C , Delaugerre C, Braun J, de Castro N, et al
    High Concentration of Raltegravir in Semen of HIV-infected Men: a sub-study of the EASIER-ANRS 138 trial.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. KHOURY G , Ewart G, Luscombe C, Miller M, et al
    The Antiviral Efficacy of the Novel Compound BIT225 Against HIV-1 Release from Human Macrophages.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. JEKLE A , Chhabra M, Lochner A, Meier S, et al
    Epitope Switching as a Novel Escape Mechanism of HIV to CCR5 Monoclonal Antibodies.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. TONI TA , Brenner BG, Asahchop EL, Ntemgwa M, et al
    Development of an Allele-Specific Polymerase Chain Reaction for Detection of the K65R Resistance Mutation in Patients Infected by Subtype C Human Immunodeficiency Virus Type 1.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
21. MARTINSON JA , Montoya CJ, Usuga X, Ronquillo R, et al
    Chloroquine Modulates HIV-1 Induced Plasmacytoid Dendritic Cell IFN{alpha}: Implication for T cell Activation.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. JENKINSON S , Thomson M, McCoy D, Edelstein M, et al
    BLOCKADE OF X4 TROPIC HIV-1 CELLULAR ENTRY BY GSK812397, A POTENT NON-COMPETITIVE CXCR4 RECEPTOR ANTAGONIST.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. MCELRATH MJ , Ballweber L, Terker A, Kreger A, et al
    Ex vivo comparison of microbicide efficacy for preventing HIV-1 genomic integration in intraepithelial vaginal cells.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. AZIJN H , Tirry I, Vingerhoets J, de Bethune MP, et al
    TMC278, a Next-Generation NNRTI, Active Against Wild-Type and NNRTI-Resistant HIV-1.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. REUMAN EC , Bachmann MH, Varghese V, Fessel WJ, et al
    Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. MARCELIN AG , Flandre P, Descamps D, Morand-Joubert L, et al
    Factors associated with virological response to etravirine in non nucleoside reverse transcriptase inhibitor experienced HIV-1 infected patients.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. DELELIS O , Thierry S, Subra F, Simon F, et al
    Impact of Y143 HIV-1 integrase mutations on resistance to Raltegravir in vitro and in vivo.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MIN S , Song I, Borland J, Chen S, et al
    Pharmacokinetics and Safety of S/GSK1349572, a Next Generation HIV Integrase Inhibitor, in Healthy Volunteers.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
29. XIE D , Yao C, Wang L, Min W, et al
    An Albumin-conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. NOWOTNY B , Schneider T, Pradel G, Schirmeister T, et al
    An inducible APOBEC3G-Vif double stable cell line as a high throughput screening platform to identify antiviral compounds.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BLAIR WS , Cao J, Fok-Seang J, Griffin P, et al
    A New Small Molecule Inhibitor Class Targeting HIV-1 Virion Maturation.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. HUET T , Kerbarh O, Schols D, Clayette P, et al
    Long-Lasting Enfuvirtide-Carrier Pentasaccharide Conjugates with Potent Anti-HIV-1 Activity.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. STANKOV MV , Lucke T, Das AM, Schmidt RE, et al
    Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside-analogue reverse transcriptase inhibitors.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
34. WANG H , Qi Z, Guo A, Mao Q, et al
    ADS-J1 inhibits HIV-1 entry by interacting with the gp41 pocket region and blocking the fusion-active gp41 core formation.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
35. SHAHRIAR R , Rhee SY, Liu TF, Fessel WJ, et al
    Nonpolymorphic HIV-1 Protease and RT Treatment-Selected Mutations.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. TARDIF MR , Gilbert C, Thibault S, Fortin JF, et al
    LFA-1 antagonists as agents limiting HIV-1 infection/transmission and potentiating the effect of the fusion inhibitor T-20.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. ALEXANDER L , Zhang S, McAuliffe B, Connors D, et al
    Inhibition of Envelope Mediated CD4+ T Cell Depletion by HIV Attachment Inhibitors.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. FRANCOIS KO , Pannecouque C, Auwerx J, Lozano V, et al
    The phtalocyanine prototype derivative Alcian Blue: the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. YANG G , Paintsil E, Dutschman GE, Grill SP, et al
    Impact of Novel HIV-1 Reverse Transcriptase Mutations, P119S and T165A on 4'-ethynylthymidine Analog Resistance Profile.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. XU H , Quan Y, Brenner BG, Bar-Magen T, et al
    HIV-1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. COAKLEY E , Reeves JD, Huang W, Mangas-Ruiz M, et al
    COMPARISON OF THE HIV-1 TROPISM PROFILES IN CLINICAL SAMPLES BY THE TROFILE AND MT-2 CELL ASSAYS.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FRANSEN S , Karmochkine M, Huang W, Weiss L, et al
    Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of HIV-1 during virologic failure.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. TACCONELLI E , De Angelis G, Cataldo MA, Mantengoli E, et al
    Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. DI MASCIO M , Srinivasula S, Bhattacharjee A, Cheng L, et al
    Antiretroviral Tissue Kinetics: in Vivo Imaging using Positron Emission Tomography.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PEREZ-ELIAS MJ , Larrousse Morellon M, Ortega E, Hernandez-Quero J, et al
    Pharmacokinetics of Fosamprenavir plus Ritonavir in HIV-1-infected Adult Subjects with Hepatic Impairment.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. MANOSUTHI W , Sungkanuparph S, Tantanathip P, Mankatitham W, et al
    Body Weight Cutoff for Daily Dosage of Efavirenz and 60-week Efficacy of Efavirenz-based Regimen in Co-infected HIV and Tuberculosis Patients Receiving Rifampin.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. LOW A , Prada N, Topper M, Vaida F, et al
    Natural Polymorphisms of HIV-1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
48. HIRT D , Urien S, Olivier M, Peyriere H, et al
    Are recommended dose of efavirenz optimal in young West African HIV-infected children? (ANRS 12103).
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CAMMETT AM , Macgregor TR, Wruck JM, Felizarta F, et al
    Pharmacokinetic Assessment of Nevirapine and Metabolites in HIV-1 Patients with Hepatic Fibrosis.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SLUIS-CREMER N , Koontz D, Bassit L, Hernandez-Santiago BI, et al
    Anti-HIV Activity, Cross-Resistance, Cytotoxicity and Intracellular Pharmacology of the 3'-Azido-2',3'-Dideoxypurine Nucleosides.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. MORELLO J , De Mendoza C, Soriano V, Anta L, et al
    Use of different inhibitory quotients to predict early virological response to Tipranavir in antiretroviral experienced HIV patients.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. HIRT D , Bardin C, Diagbouga S, Nacro B, et al
    Didanosine population pharmacokinetics in West African HIV-infected children administered once daily tablets in relation to efficacy after one year of treatment (ANRS 12103).
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
53. HATTORI S , Ide K, Nakata H, Harada H, et al
    Potent activity of a Nucleoside Reverse Transcriptase Inhibitor, 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine, against HIV-1 infection in Hu-PBMC-NOD/SCID/JAK3null (NOJ) mouse model.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. VON HENTIG N , Lotsch J
    CYP3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in HIV-1 infected adults.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SONZA S , Johnson A, Tyssen D, Spelman T, et al
    ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REPLICATION IS NOT INTRINSIC TO ALL POLYANION-BASED MICROBICIDES.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. KUGELMAN G , Tapsall JW, Goire N, Syrmis MW, et al
    Simple, rapid and inexpensive detection of Neisseria gonorrhoeae resistance mechanisms using heat-denatured isolates and SYBR-green based real-time PCR.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. JACKSON JB , Dick J, Tekle T, Simmons A, et al
    Lack of antimicrobial activity by the antiretroviral drug nevirapine against common bacterial pathogens.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
58. NTEMGWA ML , Toni TD, Brenner BG, Camacho RJ, et al
    Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2 (HIV-2).
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. WANG X , Tanaka H, Baba M, Cheng YC, et al
    Study of the retention of metabolites of 4'-Ed4T, a novel anti-HIV-1 thymidine analog, in cells.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. MURAKAMI T , Kumakura S, Yamazaki T, Tanaka R, et al
    The Novel CXCR4 Antagonist, KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. DELAUGERRE C , Flandre P, Chaix ML, Ghosn J, et al
    Protease Inhibitors Resistance Analysis in the MONARK Trial Comparing First Line Lopinavir/ritonavir Monotherapy to Lopinavir/ritonavir plus Zidovudine and Lamivudine triple therapy.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. WENNING LA , Hanley WD, Brainard DM, Petry AS, et al
    Effect of Rifampin, a Potent Inducer of Drug Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CABRERA SE , Santos D, Valverde MP, Dominguez-Gil A, et al
    POPULATION PHARMACOKINETICS OF EFAVIRENZ IN HIV PATIENTS: INFLUENCE OF THE CYP2B6 GENOTYPE.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. BARTOLO I , Rocha C, Bartolomeu J, Gama A, et al
    Antiretroviral drug resistance surveillance among treatment-naive HIV-1-infected individuals in Angola: evidence for low level of transmitted drug resistance.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. VENHOFF AC , Lebrecht D, Reuss FU, Heckl-Ostreicher B, et al
    MtDNA depletion in rat liver induced by fosalvudine tidoxil, a novel NRTI pro-drug.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. HAUSER A , Mugenyi K, Rose K, Bluethgen K, et al
    Detection and quantification of minor HIV-1 variants harbouring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
67. HANLEY WD , Wenning LA, Moreau A, Kost JT, et al
    Effect of Tipranavir + Ritonavir on Pharmacokinetics of Raltegravir.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. CAI L , Balogh E, Gochin M
    A stable extended HIV-1 gp41 coiled coil as an effective target in an assay for high affinity fusion inhibitors.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. CAMPOS W , Coopusamy D, Morris L, Mayosi BM, et al
    Cytotoxicological analysis of a gp120 binding aptamer with cross-clade Human Immunodeficiency Virus Type-1 entry inhibition properties: a comparison to conventional antiretrovirals.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. BAILEY CM , Kasiviswanathan R, Copeland WC, Anderson KS, et al
    R964C mutation of DNA polymerase {gamma} imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. TARTAGLIA A , Saracino A, Monno L, Tinelli C, et al
    Both a protective and a deleterious role for the L76V mutation.
    Antimicrob Agents Chemother. 2009;53:1724-5.
    PubMed     Text format     Related articles   
    
    
    March 2009
72. ERON JJ JR , Park JG, Haubrich R, Aweeka F, et al
    PREDICTIVE VALUE OF PHARMACOKINETIC-ADJUSTED PHENOTYPIC SUSCEPTIBILITY ON RESPONSE TO RITONAVIR-ENHANCED PROTEASE INHIBITORS (PI) IN HIV-INFECTED SUBJECTS FAILING PRIOR PI THERAPY.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. YEH RF , Rezk NL, Kashuba AD, Dumond JB, et al
    Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs During and After Pregnancy in HIV-1 Infected Women.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. FENG X , Reddy VK, Mayanja-Kizza H, Weiss LM, et al
    Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in the SCID mouse model.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. LAI MT , Munshi V, Touch S, Tynebor RM, et al
    Antiviral Activity of MK-4965: A Novel Non-nucleoside Reverse Transcriptase Inhibitor.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. WYLES DL , Kaihara KA, Korba BE, Schooley RT, et al
    ODE-(S)-HPMPA IS A POTENT AND SELECTIVE INHIBITOR OF HEPATITIS C VIRUS REPLICATION IN GENOTYPE 1A, 1B AND 2A REPLICONS.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. PRUVOST A , Negredo E, Theodoro F, Puig J, et al
    A pilot pharmacokinetic study in HIV infected patient receiving tenofovir disoproxil fumarate (TDF): Investigation of systemic and intracellular interaction between TDF and abacavir, lamivudine or lopinavir/ritonavir.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. RAKHMANINA N , van den Anker J, Baghdassarian A, Soldin S, et al
    Population Pharmacokinetics of Lopinavir Predict Suboptimal Therapeutic Concentrations in Treatment Experienced HIV-infected Children.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. HERRERA C , Cranage M, McGowan I, Anton P, et al
    Reverse transcriptase inhibitors as potential colorectal microbicides.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
80. CRESSEY TR , Van Dyke R, Jourdain G, Puthanakit T, et al
    Early Postpartum Pharmacokinetics (PK) of Lopinavir (LPV) when Initiated Intrapartum in Thai Women: a substudy of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Group P1032 study.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. IWAMOTO M , Hanley WD, Petry AS, Friedman EJ, et al
    Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. VARGHESE V , Mitsuya Y, Shahriar R, Bachmann MH, et al
    HIV-1 Isolates with the RT Mutation Q145M Retain Nucleoside and Non-Nucleoside RT Inhibitor Susceptibility.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. ZHOU XJ , Pietropaolo K, Damphousse D, Belanger B, et al
    Single-Dose Escalation and Multiple-Dose Safety, Tolerability and Pharmacokinetics of IDX899, a Candidate HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Healthy Subjects.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. OLIVEIRA M , Moisi D, Spira B, Cox S, et al
    Apricitabine does not select additional drug resistance mutations in tissue culture in HIV-1 variants containing K65R, M184V or M184V plus thymidine analogue mutations.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. VAN BAELEN K , Salzwedel K, Rondelez E, Van Eygen V, et al
    HIV-1 Susceptibility to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag SP1.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. MOYLE G , Boffito M, Fletcher C, Higgs C, et al
    STEADY-STATE PHARMACOKINETICS OF PLASMA ABACAVIR AND INTRACELLULAR CARBOVIR TRIPHOSPHATE FOLLOWING ABACAVIR 600mg ONCE DAILY AND 300mg TWICE DAILY IN HIV-INFECTED SUBJECTS.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. SKINNER MC , Stamm WE, Lampe ML
    Chlamydia trachomatis Laboratory Strains vs. Recent Clinical Isolates: Implications for Routine Microbicide Testing.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
88. TONI TA , Asahchop EL, Moisi D, Ntemgwa M, et al
    Detection of HIV-1 M184V and K103N Minority Variants in Primary HIV Infected Patients.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. TRIFONOVA RT , Doncel GF, Fichorova RN
    POLYANIONIC MICROBICIDES MODIFY TLR-MEDIATED CERVICOVAGINAL IMMUNE RESPONSES.
    Antimicrob Agents Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
90. LYNX MD , Laclair DD, McKee EE
    Effect of Zidovudine and Stavudine on mitochondrial DNA of differentiating 3T3-F442a cells is not associated with imbalanced deoxynucleotide pools.
    Antimicrob Agents Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
91. GRANT P , Wong EC, Rode R, Shafer R, et al
    Virologic Response to Lopinavir/Ritonavir-Based Antiretroviral Regimens in a Multi-Center International Clinical Cohort: Comparison of Genotypic Interpretation Scores.
    Antimicrob Agents Chemother. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: